CENTRAL NERVOUS SYSTEM DEPRESSANT ESPECIALLY

Brand	Owner (click to sort)	Address	Description
COMPAZINE	SMITHKLINE BEECHAM CORPORATION	One Franklin Plaza Philadelphia PA 19102	CENTRAL NERVOUS SYSTEM DEPRESSANT ESPECIALLY USEFUL AS AN ANTINAUSEANT AND SEDATIVE;
COMPAZINE	Evoke Pharma, Inc.	420 Stevens Avenue, Suite 370 Solana Beach CA 92075	Central nervous system depressant especially useful as an antinauseant and sedative;
COMPAZINE	PBM Pharmaceuticals, Inc.	200 Garrett Street, Suite O Charlottesville VA 22902	Central nervous system depressant especially useful as an antinauseant and sedative;
COMPAZINE	COSETTE PHARMACEUTICALS, INC.	4th Floor 200 Crossing Blvd. Bridgewater NJ 08807	Central nervous system depressant especially useful as an anti-nauseant and sedative;
REVIVE PHARMACEUTICALS	PBM Pharmaceuticals, Inc.	200 Garrett Street, Suite O Charlottesville VA 22902	Central nervous system depressant especially useful as an antinauseant and sedative and folic acid supplements;PHARMACEUTICALS;
STELAZINE	GLAXOSMITHKLINE	251 Little Falls Drive Wilmington DE 19808	Central Nervous System Depressant Especially Useful as a Tranquilizing Agent;
TERMARIL	SMITHKLINE CORPORATION, DBA, SMITH KLINE & FRENCH LABORATORIES	PHILADELPHIA PA	CENTRAL NERVOUS SYSTEM DEPRESSANT ESPECIALLY USEFUL AS AN ANTI-PRURITIC AND SEDATIVE;
THORAZINE	SMITHKLINE BEECHAM CORPORATION	One Franklin Plaza Philadelphia PA 19102	CENTRAL NERVOUS SYSTEM DEPRESSANT ESPECIALLY USEFUL AS A SEDATIVE, ANTI-NAUSEANT, AND ANTI-PRURITIC;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

Methods and compositions for modulating the axonal outgrowth of central nervous system neurons are provided. Methods for stimulating the axonal outgrowth of central nervous system neurons following an injury (e.g., stroke, Traumatic Brain Injury, cerebral aneurism, spinal cord injury and the like) and methods for inhibiting the axonal outgrowth of central nervous system neurons in conditions such as epilepsy, e.g., posttraumatic epilepsy, and neuropathic pain syndrome, are also provided. These methods generally involve contacting the central nervous system neurons with a compound that modulates the activity of N-kinase, or analog thereof. The methods and compositions are particularly useful for modulating the axonal outgrowth of mammalian central nervous system neurons, such as mammalian cortical neurons or retinal ganglion cells. Pharmaceutical and packaged formulations that include the compounds of the invention that modulate the activity of N-kinase are also provided.